The historical rank and industry rank for CTI BioPharma's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, CTI BioPharma's highest Price to Tangible Book Ratio was 81.87. The lowest was 0.00. And the median was 4.72.
CTIC's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.68 * Ranked among companies with meaningful Price-to-Tangible-Book only.
CTI BioPharma Price-to-Tangible-Book Historical Data
The historical data trend for CTI BioPharma's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CTI BioPharma's Price-to-Tangible-Book
For the Biotechnology subindustry, CTI BioPharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CTI BioPharma's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CTI BioPharma's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where CTI BioPharma's Price-to-Tangible-Book falls into.
CTI BioPharma Price-to-Tangible-Book Calculation
CTI BioPharma's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
CTI BioPharma Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of CTI BioPharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
CTI BioPharma (CTI BioPharma) Business Description
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CTIC has been successfully added to your 